BTIG analyst Ryan Zimmerman maintained a Hold rating on Orthofix (OFIX – Research Report) today. The company’s shares opened today at ...

In a report released today, Ryan Zimmerman from BTIG maintained a Hold rating on Integra Lifesciences (IART – Research Report). The company’s ...

The S&P 500 may be due for a short-term bounce after its pullback from last week's record highs — but don't expect it to last ...

The eatertainment brand saw same-store sales fall 7.7% last quarter, and failed to maintain a leverage ratio required by a financing covenant.

Morgan Stanley cut shares of Hims & Hers Health (NYSE:HIMS – Free Report) from an overweight rating to an equal weight rating ...

Indeed, one major draw of international stocks is that they look much cheaper compared with their U.S. counterparts. The S&P 500 traded at 22 times forward earnings as of Tuesday, while the STOXX 600 ...

Investors attending the conference wishing to schedule a meeting are encouraged to contact BTIG to schedule. Event: BTIG’s MedTech, Digital Health, Life Science & Diagnostic Tools Conference 2025 ...

On Tuesday, BTIG analyst Thomas Catherwood maintained a Neutral rating on shares of Kilroy Realty Corporation (NYSE:KRC), following the company's release of its fourth-quarter 2024 financial results.

On Monday, BTIG initiated coverage on ARMOUR Residential (NYSE:ARR) with a Neutral rating. The firm's analysis suggests a potential for a 20%+ total return, factoring in a steady 15% dividend yield ...

On Monday, BTIG analyst Andrew Harte maintained a Neutral rating on Global Payments Inc. (NYSE:GPN) stock, despite an approximate 11% increase in share value since the company's third-quarter 2024 ...